乐普制药科技

Lepu Pharmaceutical Technology is a prominent Chinese pharmaceutical company and a key subsidiary of the Lepu Medical group. The company focuses on the development, production, and commercialization of small molecule drugs, particularly in the cardiovascular, metabolic, and oncology therapeutic areas. It is well-known for its high-quality generic portfolio, including market-leading versions of Atorvastatin and Clopidogrel, which are central to China's national volume-based procurement programs. Lepu Pharmaceutical Technology operates advanced manufacturing bases that adhere to international GMP standards, ensuring a stable supply of essential medicines. By integrating with Lepu Medical's broader ecosystem of medical devices and digital health, the company provides comprehensive solutions for chronic disease management.